Can Self-Compassion training break the isolation of life with a stoma?
NCT ID NCT07809074
First seen Sep 09, 2026 · Last updated Sep 10, 2026 · Updated 1 time
Summary
Colorectal cancer patients who live with a stoma often face stigma, social anxiety, and loneliness. Researchers are testing a six-week mindfulness and self-compassion program adapted for these patients. The pilot trial enrolls 20 adults who have finished active treatment and speak Cantonese or Mandarin. The study measures whether the program is practical to run and whether it changes loneliness, self-compassion, stigma, and social anxiety.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- a mindfulness and self-compassion training program delivered in six weekly group sessions
- What this could lead to
- If it works, this could offer a low-risk, group-based way to help ostomy patients feel less isolated and more confident in social situations.
- What could go wrong
- This is a small pilot study of 20 people, so it may not show clear benefits or apply to other patients. Participants must attend six sessions, and the program may not suit everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 20 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2026
An estimate. Start dates often move.
- Expected to finish
-
Apr 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * age ≥ 18 years old; * colon cancer or rectal cancer patients with stoma; * the stoma won't be reversed within 3 months when conducting the baseline survey; * after surgery of stoma formation; * complete active treatment; * Cantonese or Mandarin speaking. Exclusion Criteria: * Diagnosed with cognitive impairment or dementia (e.g., Alzheimer's disease) as determined using International Classification of Diseases (ICD-10) criteria; * diagnosis of a severe mental disorder; * could not provide informed consent.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Colorectal cancer (CRC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Alpha radiation targets tumors in new cancer trial
- Why are more younger adults getting colorectal cancer? a national study digs into the data
- New drug combo aims to boost response in Hard-to-Treat colorectal cancer
- First-in-Class cancer drug targets Hard-to-Treat tumors
- New pill targets Hard-to-Treat cancers with a specific gene mutation
- AI eye on cancer: robot helps spot hidden polyps